Polyamine transporter system (PTS)

The polyamine transporter system (PTS) is a complex network of membrane proteins responsible for the uptake, export, and intracellular sequestration of polyamines such as putrescine, spermidine, and spermine [Frontiers in Molecular Biosciences, 2024]. These organic cations are essential for fundamental cellular processes, including DNA replication, protein synthesis, and cell proliferation [NIH, 2010]. In humans, the PTS is not a single entity but comprises various proteins, including solute carriers (e.g., SLC3A2, SLC22A16), P-type ATPases (e.g., ATP13A2), and endocytic pathways involving caveolin-1 [Frontiers in Molecular Biosciences, 2024]. Dysregulation of the PTS is a hallmark of several diseases; for instance, cancer cells frequently upregulate polyamine uptake to support rapid growth, while mutations in transporters like ATP13A2 are linked to neurodegenerative disorders such as Parkinson's disease [PNAS, 2020]. Therapeutic strategies targeting the PTS often involve polyamine transport inhibitors (PTIs) like AMXT-1501, which are frequently used in combination with biosynthesis inhibitors to achieve profound polyamine depletion in tumor cells [NIH, 2024]. Additionally, recent studies have identified the vesicular polyamine transporter (VPAT/SLC18B1) as a target for drugs like tetrabenazine in the context of neurological disorders [Nature Communications, 2025]. The system's complexity, involving multiple redundant pathways, presents both a challenge for drug development and an opportunity for highly selective therapeutic interventions.

Other names

Polyamine transport systemPolyamine uptake systemPTS

Inhibition of polyamine uptake; Inhibition of vesicular polyamine transport; Competitive inhibition of polyamine binding sites; Polyamine depletion (when combined with biosynthesis inhibitors)